Advertisement
Skip to Content

Columbia Corporate Income Inst SRINX

Medalist Rating as of | See Columbia Threadneedle Investment Hub
  • NAV / 1-Day Return 8.82  /  0.24 %
  • Total Assets 1.6 Bil
  • Adj. Expense Ratio
  • Expense Ratio 0.620%
  • Distribution Fee Level Above Average
  • Share Class Type Institutional
  • Category Corporate Bond
  • Credit Quality / Interest Rate Sensitivity Medium / Moderate
  • Min. Initial Investment 2,000
  • Status Open
  • TTM Yield 3.55%
  • Effective Duration 6.22 years

Morningstar’s Analysis SRINX

Will SRINX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Concentration concerns.

Senior Analyst Peter Marchese

Peter Marchese

Senior Analyst

Summary

Columbia Corporate Income benefits from an experienced team and a well-structured process, but its substantial industry concentrations have led to a bumpy record. It earns a Morningstar Analyst Rating of Neutral across most share classes, though its expensive C share class is rated Negative.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings SRINX

  • Current Portfolio Date Mar 31, 2023
  • Equity Holdings 1
  • Bond Holdings 585
  • Other Holdings 11
  • % Assets in Top 10 Holdings 16.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Columbia Short-Term Cash

4.07
65,069,119
Cash and Equivalents

UnitedHealth Group Inc. 5.3%

1.91
30,537,153
Corporate

Verizon Communications Inc. 2.55%

1.90
30,352,374
Corporate

Bank of America Corporation 1.922%

1.75
27,991,353
Corporate

Amgen Inc. 5.75%

1.73
27,574,345
Corporate

WarnerMedia Holdings Inc. 5.391%

1.68
26,897,235
Corporate

NiSource Inc. 1.7%

1.67
26,677,535
Corporate

JPMorgan Chase & Co. 2.58%

1.61
25,659,367
Corporate

BAE Systems PLC 1.9%

1.53
24,406,060
Corporate

Carrier Global Corporation 2.722%

1.52
24,285,814
Corporate